Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 124

1.

Influence of anti-infliximab antibodies and residual infliximab concentrations on the occurrence of acquired drug resistance to infliximab in rheumatoid arthritis patients.

Finckh A, Dudler J, Wermelinger F, Ciurea A, Kyburz D, Gabay C, Bas S; physicians of SCQM.

Joint Bone Spine. 2010 Jul;77(4):313-8. doi: 10.1016/j.jbspin.2010.02.021. Epub 2010 May 14.

PMID:
20471890
[PubMed - indexed for MEDLINE]
2.

Severe infusion reactions to infliximab: aetiology, immunogenicity and risk factors in patients with inflammatory bowel disease.

Steenholdt C, Svenson M, Bendtzen K, Thomsen OØ, Brynskov J, Ainsworth MA.

Aliment Pharmacol Ther. 2011 Jul;34(1):51-8. doi: 10.1111/j.1365-2036.2011.04682.x. Epub 2011 May 3.

PMID:
21535447
[PubMed - indexed for MEDLINE]
3.

Monitoring patients treated with anti-TNF-alpha biopharmaceuticals: assessing serum infliximab and anti-infliximab antibodies.

Svenson M, Geborek P, Saxne T, Bendtzen K.

Rheumatology (Oxford). 2007 Dec;46(12):1828-34.

PMID:
18032541
[PubMed - indexed for MEDLINE]
Free Article
4.
5.

Time-course of health status in patients with rheumatoid arthritis during the first year of treatment with infliximab.

Ban A, Inaba M, Furumitsu Y, Okamoto K, Yukioka K, Goto H, Nishizawa Y.

Biomed Pharmacother. 2010 Feb;64(2):107-12. doi: 10.1016/j.biopha.2009.04.035. Epub 2009 Nov 5.

PMID:
19944558
[PubMed - indexed for MEDLINE]
6.

Relationship between serum trough infliximab levels, pretreatment C reactive protein levels, and clinical response to infliximab treatment in patients with rheumatoid arthritis.

Wolbink GJ, Voskuyl AE, Lems WF, de Groot E, Nurmohamed MT, Tak PP, Dijkmans BA, Aarden L.

Ann Rheum Dis. 2005 May;64(5):704-7. Epub 2004 Oct 14.

PMID:
15485995
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Prospective cohort study of effects of infliximab on rheumatoid factor, anti-cyclic citrullinated peptide antibodies and antinuclear antibodies in patients with long-standing rheumatoid arthritis.

Bruns A, Nicaise-Roland P, Hayem G, Palazzo E, Dieudé P, Grootenboer-Mignot S, Chollet-Martin S, Meyer O.

Joint Bone Spine. 2009 May;76(3):248-53. doi: 10.1016/j.jbspin.2008.09.010. Epub 2009 Feb 8.

PMID:
19208451
[PubMed - indexed for MEDLINE]
8.

Anti-infliximab antibodies in patients with rheumatoid arthritis who require higher doses of infliximab to achieve or maintain a clinical response.

Haraoui B, Cameron L, Ouellet M, White B.

J Rheumatol. 2006 Jan;33(1):31-6.

PMID:
16395747
[PubMed - indexed for MEDLINE]
9.

Influence of immunogenicity on the efficacy of long-term treatment with infliximab in rheumatoid arthritis.

Pascual-Salcedo D, Plasencia C, Ramiro S, Nuño L, Bonilla G, Nagore D, Ruiz Del Agua A, Martínez A, Aarden L, Martín-Mola E, Balsa A.

Rheumatology (Oxford). 2011 Aug;50(8):1445-52. doi: 10.1093/rheumatology/ker124. Epub 2011 Mar 22.

PMID:
21427177
[PubMed - indexed for MEDLINE]
Free Article
10.
11.

Increased efficacy of infliximab associated with methotrexate in ankylosing spondylitis.

Pérez-Guijo VC, Cravo AR, Castro Mdel C, Font P, Muñoz-Gomariz E, Collantes-Estevez E.

Joint Bone Spine. 2007 May;74(3):254-8. Epub 2007 Mar 1.

PMID:
17387031
[PubMed - indexed for MEDLINE]
12.

Short-term effect of anti-TNF-alpha therapy on nitric oxide production in patients with severe rheumatoid arthritis.

Gonzalez-Gay MA, Garcia-Unzueta MT, Berja A, Vazquez-Rodriguez TR, Miranda-Filloy JA, Gonzalez-Juanatey C, de Matias JM, Martin J, Dessein PH, Llorca J.

Clin Exp Rheumatol. 2009 May-Jun;27(3):452-8.

PMID:
19604438
[PubMed - indexed for MEDLINE]
13.

Infliximab but not methotrexate induces extra-high levels of VLDL-triglyceride in patients with rheumatoid arthritis.

Saiki O, Takao R, Naruse Y, Kuhara M, Imai S, Uda H.

J Rheumatol. 2007 Oct;34(10):1997-2004. Epub 2007 Sep 1.

PMID:
17787045
[PubMed - indexed for MEDLINE]
14.

Correlation of antinuclear antibody and anti-double-stranded DNA antibody with clinical response to infliximab in patients with rheumatoid arthritis: a retrospective clinical study.

Yukawa N, Fujii T, Kondo-Ishikawa S, Yoshifuji H, Kawabata D, Nojima T, Ohmura K, Usui T, Mimori T.

Arthritis Res Ther. 2011;13(6):R213. doi: 10.1186/ar3546. Epub 2011 Dec 22.

PMID:
22192852
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

The frequency of anti-infliximab antibodies in patients with rheumatoid arthritis treated in routine care and the associations with adverse drug reactions and treatment failure.

Krintel SB, Grunert VP, Hetland ML, Johansen JS, Rothfuss M, Palermo G, Essioux L, Klause U.

Rheumatology (Oxford). 2013 Jul;52(7):1245-53. doi: 10.1093/rheumatology/ket017. Epub 2013 Mar 4.

PMID:
23459699
[PubMed - indexed for MEDLINE]
16.

Sustained effect after lowering high-dose infliximab in patients with rheumatoid arthritis: a prospective dose titration study.

van den Bemt BJ, den Broeder AA, Snijders GF, Hekster YA, van Riel PL, Benraad B, Wolbink GJ, van den Hoogen FH.

Ann Rheum Dis. 2008 Dec;67(12):1697-701. doi: 10.1136/ard.2007.083683. Epub 2008 Jan 31.

PMID:
18245109
[PubMed - indexed for MEDLINE]
17.

Formation of antibodies against infliximab and adalimumab strongly correlates with functional drug levels and clinical responses in rheumatoid arthritis.

Radstake TR, Svenson M, Eijsbouts AM, van den Hoogen FH, Enevold C, van Riel PL, Bendtzen K.

Ann Rheum Dis. 2009 Nov;68(11):1739-45. doi: 10.1136/ard.2008.092833. Epub 2008 Nov 19.

PMID:
19019895
[PubMed - indexed for MEDLINE]
18.

Low prevalence of antibodies to cyclic citrullinated peptide in patients with inflammatory bowel disease regardless of the presence of arthritis.

Papamichael K, Tsirogianni A, Papasteriades C, Mantzaris GJ.

Eur J Gastroenterol Hepatol. 2010 Jun;22(6):705-9. doi: 10.1097/MEG.0b013e32832e2bc4.

PMID:
19525851
[PubMed - indexed for MEDLINE]
19.

Clinical implications of variations in anti-infliximab antibody levels in patients with inflammatory bowel disease.

Steenholdt C, Al-khalaf M, Brynskov J, Bendtzen K, Thomsen OØ, Ainsworth MA.

Inflamm Bowel Dis. 2012 Dec;18(12):2209-17. doi: 10.1002/ibd.22910. Epub 2012 Feb 16.

PMID:
22344964
[PubMed - indexed for MEDLINE]
20.

Infliximab and methotrexate in the treatment of rheumatoid arthritis: a systematic review and meta-analysis of dosage regimens.

Zintzaras E, Dahabreh IJ, Giannouli S, Voulgarelis M, Moutsopoulos HM.

Clin Ther. 2008 Nov;30(11):1939-55. doi: 10.1016/j.clinthera.2008.11.007. Review.

PMID:
19108784
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk